期刊
EPIGENETICS
卷 3, 期 1, 页码 28-37出版社
TAYLOR & FRANCIS INC
DOI: 10.4161/epi.3.1.5736
关键词
class IHDAC; class IIHDAC; Sirt1; HDAC inhibitors; colon cancer; transcription
资金
- NCI NIH HHS [R01 CA100823-04, R01 CA100823] Funding Source: Medline
- NATIONAL CANCER INSTITUTE [R01CA100823] Funding Source: NIH RePORTER
The histone deacetylase (HDAC) family of transcriptional co-repressors have emerged as important regulators of colon cell maturation and transformation. Pharmacological inhibitors of class I and II HDAC activity (HDACi) are potent inducers of growth arrest, differentiation and apoptosis of colon cancer cells in vitro and in vivo, implicating a role for these HDACs in tumor promotion. Consistent with this role, expression of several HDACs are upregulated in colon tumors, while downregulation of specific HDACs inhibits growth of colon cancer cells in vitro and intestinal tumorigenesis in vivo. This review focuses on the function and transcriptional mechanisms by which class I and II HDACs regulate colon cell maturation and transformation, and on the mechanisms by which HDACi induce growth arrest, differentiation and apoptosis of colon cancer cells. The emerging role of the class III HDAC, Sirt1, in colon cancer progression is also discussed.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据